A NOVEL CLASS-C BETA-LACTAMASE (FOX-2) IN ESCHERICHIA-COLI CONFERRINGRESISTANCE TO CEPHAMYCINS

Citation
A. Bauernfeind et al., A NOVEL CLASS-C BETA-LACTAMASE (FOX-2) IN ESCHERICHIA-COLI CONFERRINGRESISTANCE TO CEPHAMYCINS, Antimicrobial agents and chemotherapy, 41(9), 1997, pp. 2041-2046
Citations number
26
Categorie Soggetti
Pharmacology & Pharmacy",Microbiology
ISSN journal
00664804
Volume
41
Issue
9
Year of publication
1997
Pages
2041 - 2046
Database
ISI
SICI code
0066-4804(1997)41:9<2041:ANCB(I>2.0.ZU;2-J
Abstract
An Escherichia coli strain resistant to a broad spectrum of beta-lacta ms, including cephamycins, was isolated from a patient suffering from urinary tract infection. A resistance plasmid (pRjlVP-7) was transferr ed from the clinical isolate to an Escherichia coli recipient. Both st rains Produce a cefoxitin-hydrolyzing beta-lactamase focusing at pi 6. 7. The phenotype was similar to that of a Klebsiella pneumoniae strain producing cephamycinase FOX-1, so primers were selected from the FOX- 1 sequence to amplify the bla gene of the transconjugant. The PCR prod uct obtained was sequenced: The percentage of identity of the deduced aminoacid sequence with sequences of other AmpC-type beta-lactamases w as 96.9% with FOX-1, 74.9% with CMY-1, and 67.7% with MOX-1. This new plasmid-mediated enzyme is most closely related to FOX-1 (11 amino aci d exchanges). We therefore propose the designation FOX-2.